α-fetoprotein: Reevaluation in hepatology

Hepatology - Tập 12 Số 6 - Trang 1420-1432 - 1990
Kazuhisa Taketa1
1Health Research Center, Kagawa University, Takamatsu, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bergstrand, 1956, Scand J Clin Lab Invest, 8, 174, 10.3109/00365515609049266

Halbrecht, 1956, Nature, 178, 794, 10.1038/178794a0

Abelev, 1963, Transplant Bull, 1, 174, 10.1097/00007890-196301020-00004

The discovery of fetal globulin in patients with primary cancer of the liver [Abstract]. First International Biochemistry Congress of the USSR. Moscow: Academy of Sciences USSR, 1963: 274.

Tatarinov, 1964, Vopr Med Khim, 10, 90

Abelev, 1967, Int J Cancer, 2, 551, 10.1002/ijc.2910020517

Masopust, 1968, Int J Cancer, 3, 364, 10.1002/ijc.2910030306

Tatarinov, 1989, J Nucl Med Allied Sci, 33, 5

Alpert, 1968, N Engl J Med, 278, 984, 10.1056/NEJM196805022781804

Ruoslahti, 1971, Int J Cancer, 8, 374, 10.1002/ijc.2910080304

Nishi, 1973, Gann Monogr Cancer Res, 14, 79

Ruoslahti, 1974, Br Med J, 8, 527, 10.1136/bmj.2.5918.527

Human alpha-1 fetoprotein. In: , eds. Hepatocellular carcinoma. New York: John Wiley & Sons, 1976: 353–367.

. Alpha-fetoprotein in liver cirrhosis. I. Prognostic and diagnostic significance of the transient rise of serum alpha-fetoprotein. In: ed. Carcinoembryonic proteins. Vol I. Amsterdam:Elsevier/North-Holland Biomedical Press, 1979: 219–231.

Gleiberman, 1985, Int Rev Cytol, 95, 229, 10.1016/S0074-7696(08)60583-5

Sawadaishi, 1988, Mol Cell Biol, 8, 5179, 10.1128/MCB.8.12.5179

Nakabayashi, 1989, J Biol Chem, 264, 266, 10.1016/S0021-9258(17)31253-X

Tamaoki, 1989, J Tumor Marker Oncol, 4, 161

Di Bisceglie, 1989, Cancer, 64, 2117, 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7

Toukan, 1990, Gastroenterology, 98, a640

Furukawa, 1984, Tumor Biol, 5, 327

Hirai, 1987, Tumor Biol, 8, 86, 10.1159/000217500

Bręborowicz, 1981, Scand J Immunol, 14, 15, 10.1111/j.1365-3083.1981.tb00179.x

Miyazaki, 1981, Acta Hepatol Jpn, 22, 1559, 10.2957/kanzo.22.1559

Hirai, 1979, Methods Cancer Res, 18, 39

Wepsic, 1979, Gastroenterology, 77, 787, 10.1016/0016-5085(79)90238-5

Sell, 1981, Hum Pathol, 12, 959, 10.1016/S0046-8177(81)80252-3

, eds. Biological activities of alpha1fetoprotein. Vol II. Boca Raton, Fla: CRC Press, 1987: 1–262.

, eds. Biological activities of alpha1fetoprotein. Vol II. Boca Raton, Fla: CRC Press, 1989: 1–288.

Abelev, 1989, Tumor Biol, 10, 63, 10.1159/000217596

1989, J Nucl Med Allied Sci, 33, 1

Morinaga, 1983, Proc Natl Acad Sci USA, 80, 4604, 10.1073/pnas.80.15.4604

Gibbs, 1987, Biochemistry, 26, 1332, 10.1021/bi00379a020

Nunez, 1974, Biochem Biophys Res Commun, 57, 126, 10.1016/S0006-291X(74)80366-9

Yang, 1985, Proc Natl Acad Sci USA, 82, 7994, 10.1073/pnas.82.23.7994

Cooke, 1985, J Clin Invest, 76, 2420, 10.1172/JCI112256

Nakabayashi, 1982, Cancer Res, 42, 3858

Egawa, 1987, Clin Chim Acta, 167, 273, 10.1016/0009-8981(87)90347-0

Parmelee, 1978, J Biol Chem, 253, 2114, 10.1016/S0021-9258(17)38047-X

Villacampa, 1984, Biochem Biophys Res Commun, 122, 1322, 10.1016/0006-291X(84)91236-1

Geuskens, 1986, J Cell Physiol, 128, 389, 10.1002/jcp.1041280307

Hasegawa, 1973, Gann Monogr Cancer Res, 14, 129

Murgita, 1975, J Exp Med, 141, 269, 10.1084/jem.141.2.269

Yachnin, 1980, Oncodev Biol Med, 1, 273

Masseyeff, 1974, Digestion, 10, 17, 10.1159/000197519

Chayvialle, 1977, Digestion, 16, 118, 10.1159/000198062

, , , , . Monitoring very low levels of AFP in the early detection of tumor recurrency. In: ed. Protides of the biological fluids, XXXI. Oxford: Pergamon Press, 1984: 395–398.

Ball, 1990, Gastroenterology, 98, a271

Sato, 1984, Acta Hepatol Jpn, 25, 231, 10.2957/kanzo.25.231

Tsuchida, 1978, J Pediatr Surg, 13, 155, 10.1016/S0022-3468(78)80010-4

Ferguson-Smith, 1983, J Med Genet, 20, 458

Ferguson-Smith, 1985, Cytogenet Cell Genet, 40, 628

Greenberg, 1990, Gastroenterology, 98, 1083, 10.1016/0016-5085(90)90037-2

Chandra, 1975, Br Med J, 29, 714, 10.1136/bmj.1.5960.714

Okimoto, 1989, Jpn J Gastroenterol, 86, 2812

Silver, 1974, Cancer Res, 34, 244

Chen, 1977, Cancer, 40, 779, 10.1002/1097-0142(197708)40:2<779::AID-CNCR2820400227>3.0.CO;2-Y

Alpert, 1978, Gastroenterology, 74, 856, 10.1016/0016-5085(78)90141-5

Chen, 1979, Cancer, 44, 984, 10.1002/1097-0142(197909)44:3<984::AID-CNCR2820440328>3.0.CO;2-6

Sugimoto, 1987, Am J Gastroenterol, 82, 69

Liaw, 1987, Hepatology, 7, 20, 10.1002/hep.1840070106

Karvountzis, 1974, Ann Intern Med, 80, 156, 10.7326/0003-4819-80-2-156

Bloomer, 1977, Gastroenterology, 72, 479, 10.1016/S0016-5085(77)80260-6

Bloomer, 1975, JAMA, 233, 38, 10.1001/jama.1975.03260010040018

Bergmann, 1985, Am J Gastroenterol, 80, 810

Francioni, 1989, J Nucl Med Allied Sci, 33, 103

Liaw, 1986, Liver, 6, 133, 10.1111/j.1600-0676.1986.tb00279.x

Ebara, 1986, Gastroenterology, 90, 289, 10.1016/0016-5085(86)90923-6

Sheu, 1985, Gastroenterology, 89, 259, 10.1016/0016-5085(85)90324-5

Chen, 1984, Gastroenterology, 86, 1404, 10.1016/S0016-5085(84)80151-1

Bélanger, 1973, Pathol Biol (Paris), 21, 449

Waldmann, 1972, Lancet, 2, 1112, 10.1016/S0140-6736(72)92717-1

Nomura, 1989, Cancer, 64, 1700, 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z

Liver Cancer Study Group of Japan., 1987, Cancer, 60, 1400, 10.1002/1097-0142(19870915)60:6<1400::AID-CNCR2820600639>3.0.CO;2-W

Liver Cancer Study Group of Japan., 1988, Acta Hepatol Jpn, 29, 1619, 10.2957/kanzo.29.1619

Taketa, 1989, AFP. J Med Technol, 33, 1380

Shinagawa, 1984, Gastroenterology, 86, 495, 10.1016/S0016-5085(84)80020-7

Sonoda, 1989, Hepatology, 10, 1003, 10.1002/hep.1840100619

Okuda, 1986, Hepatology, 6, 729, 10.1002/hep.1840060432

Kondo, 1989, Hepatology, 9, 751, 10.1002/hep.1840090516

Brumm, 1989, Histopathology, 14, 503, 10.1111/j.1365-2559.1989.tb02186.x

Okuda, 1989, Gastroenterology, 97, 140, 10.1016/0016-5085(89)91427-3

Paradinas, 1982, Br Med J, 285, 840, 10.1136/bmj.285.6345.840

Akai, 1973, Gann Monogr Cancer Res, 14, 149

Waldmann, 1974, Cancer, 34, 1510, 10.1002/1097-0142(197410)34:8+<1510::AID-CNCR2820340824>3.0.CO;2-Y

McIntire, 1975, Cancer Res, 35, 991

Murakami, 1985, J Hiroshima Med Assoc, 38, 1204

Ishikura, 1986, Cancer, 58, 119, 10.1002/1097-0142(19860701)58:1<119::AID-CNCR2820580121>3.0.CO;2-U

Trojan, 1982, Oncodev Biol Med, 3, 12

Mackiewicz, 1980, Oncodev Biol Med, 1, 251

Taketa, 1989, Tumor Biol, 10, 275, 10.1159/000217625

. Biosynthesis of alpha-fetoprotein by MCF7 human breast cancer cells. Int J Cancer 1985; 315–319.

Sarcione, 1987, Dis Markers, 5, 75

Mihalev, 1978, Neoplasma, 23, 103

Wyscocki, 1987, Acta Paediatr Hung, 28, 119

Koji, 1980, Cancer Res, 40, 3013

Goldenberg, 1980, Cancer, 45, 2500, 10.1002/1097-0142(19800515)45:10<2500::AID-CNCR2820451006>3.0.CO;2-J

Springolo, 1989, Hepatology, 9, 116, 10.1002/hep.1840090120

Galun, 1990, Hepatology, 11, 578, 10.1002/hep.1840110409

Moro, 1984, Nucl Med Commun, 5, 5, 10.1097/00006231-198401000-00002

Abelev, 1971, Adv Cancer Res, 14, 295, 10.1016/S0065-230X(08)60523-0

Taketa, 1975, Ann NY Acad Sci, 259, 80, 10.1111/j.1749-6632.1975.tb25404.x

Watanabe, 1976, Cancer Res, 36, 2171

Watanabe, 1976, Int J Cancer, 17, 518, 10.1002/ijc.2910170415

Watanabe, 1976, Experientia, 32, 470, 10.1007/BF01920802

Sell, 1974, J Natl Cancer Inst, 53, 289, 10.1093/jnci/53.1.289

Sell, 1976, Am J Clin Pathol, 66, 847, 10.1093/ajcp/66.5.847

Nagasue, 1980, Dig Dis Sci, 25, 243, 10.1007/BF01308512

Taketa, 1988, Cancer Res, 48, 467

Tokiwa, 1987, In Vitro, 23, 830

Forrester, 1978, Med Hypotheses, 4, 31, 10.1016/0306-9877(78)90024-5

Locker, 1987, Carcinogenesis, 8, 241, 10.1093/carcin/8.2.241

Nahon, 1988, J Biol Chem, 263, 11436, 10.1016/S0021-9258(18)37976-6

Nowell, 1976, Science, 194, 23, 10.1126/science.959840

Nakabayashi, 1985, Cancer Res, 45, 6379

Di Bisceglee, 1986, Br J Cancer, 54, 779, 10.1038/bjc.1986.240

Otsuru, 1988, Cancer, 62, 1105, 10.1002/1097-0142(19880915)62:6<1105::AID-CNCR2820620613>3.0.CO;2-Z

Alpert, 1972, J Biol Chem, 247, 3792, 10.1016/S0021-9258(19)45104-1

Lester, 1978, Immunology, 34, 189

Lester, 1978, Biochim Biophys Acta, 536, 165, 10.1016/0005-2795(78)90062-4

Purves, Lancet 1070, 2, 464

Comparability of carbohydrate heterogeneity patterns of human alpha-fetoprotein in different biological fluids. In: ed. Lectins: biology—biochemistry—clinical biochemistry. Vol II. Berlin: Walter de Gruyter, 1982; 433–444.

Smith, 1973, Biochim Biophys Acta, 317, 231, 10.1016/0005-2795(73)90218-3

Bøg-Hansen, 1975, Scand J Immunol, 4, 141, 10.1111/j.1365-3083.1975.tb03820.x

Kerckaert, 1979, Biochim Biophys Acta, 576, 99, 10.1016/0005-2795(79)90488-4

Buamah, 1986, Clin Chem, 32, 2083, 10.1093/clinchem/32.11.2083

Chan, 1986, Clin Chem, 32, 2143, 10.1093/clinchem/32.12.2143

Aoyagi, 1984, Gann, 75, 809

Carbohydrate microheterogeneity of maternal serum AFP in pregnancy. In: ed. Pregnancy proteins in animals. Berlin: Walter de Gruyter, 1986; 41–47.

Taketa, 1985, Electrophoresis, 6, 492, 10.1002/elps.1150061005

Taketa, 1987, Electrophoresis, 8, 409, 10.1002/elps.1150080908

Taketa, 1989, Electrophoresis, 10, 562, 10.1002/elps.1150100805

Kinoshita, 1989, Clin Chim Acta, 179, 143, 10.1016/0009-8981(89)90160-5

Feizi, 1983, Biochem Soc Transactions, 11, 263, 10.1042/bst0110263

Kitagawa, 1986, Jpn J Cancer Res, 77, 1012

Suzuki, 1987, Br J Cancer, 55, 147, 10.1038/bjc.1987.30

Sittenfeld, 1988, J Immunol Methods, 106, 19, 10.1016/0022-1759(88)90266-9

Suzuki, 1990, Ann Clin Biochem, 27, 121, 10.1177/000456329002700206

Taketa, 1986, Cancer Lett, 31, 325, 10.1016/0304-3835(86)90155-2

Taketa, 1987, J Tumor Marker Oncol, 2, 133

Ruoslahti, 1978, Int J Cancer, 22, 515, 10.1002/ijc.2910220502

Smith, 1983, Ann N Y Acad Sci, 417, 69, 10.1111/j.1749-6632.1983.tb32850.x

Ishiguro, 1984, Am J Reprod Immunol, 5, 102, 10.1111/j.1600-0897.1984.tb00296.x

Buamah, 1984, Clin Chim Acta, 139, 313, 10.1016/0009-8981(84)90277-8

Mackiewicz, 1984, Placenta, 5, 373, 10.1016/S0143-4004(84)80017-X

Taketa, 1990, Gastroenterology, 99, 508, 10.1016/0016-5085(90)91034-4

Tsuchida, 1989, Tumor Biol, 10, 289, 10.1159/000217628

Ishiguro, 1986, Jpn J Surg, 16, 16, 10.1007/BF02471064

Yoshimoto, 1987, Cancer, 60, 2744, 10.1002/1097-0142(19871201)60:11<2744::AID-CNCR2820601126>3.0.CO;2-H

, . Three-dimensional crossed immunoelectrophoresis for two-dimensional lectin affinity electrophoresis of human α-fetoprotein. In: ed. Electrophoresis '84. Veinheim: Verlag Chemie, 1984; 137–140.

Taketa, 1985, Tumor Biol, 6, 519

Ishiguro, 1985, Tumor Biol, 6, 195

Taketa, 1990, Tumor Biol, 11, 220, 10.1159/000217658

Ishiguro, 1989, Dis Markers, 7, 239

Tsuchida, 1989, J Pediatr Surg, 24, 350, 10.1016/S0022-3468(89)80267-2

Taketa, 1989, Electrophoresis, 10, 825, 10.1002/elps.1150101205

Ishiguro, 1986, Dis Markers, 4, 293

. AFP carbohydrate heterogeneity as a marker for premalignancy and malignancy. In: , eds. Biological activities of alpha1-fetoprotein. Vol. 2. Boca Raton, Fla: CRC Press, 1989; 35–43.

Yoshima, 1980, Cancer Res, 40, 4276

Yamashita, 1983, Cancer Res, 43, 4691

Ogata, 1975, J Biochem (Tokyo), 78, 678, 10.1093/oxfordjournals.jbchem.a130956

Yamashita, 1983, J Biol Chem, 258, 14753, 10.1016/S0021-9258(17)43721-5

Aoyagi, 1985, Biochim Biophys Acta, 830, 217, 10.1016/0167-4838(85)90277-8

Kornfeld, 1981, J Biol Chem, 256, 6633, 10.1016/S0021-9258(19)69037-X

. Three-dimensional affinity electrophoresis of human alpha-fetoprotein. In: ed. Lectins: biology—biochemistry– clinical biochemistry. Vol I. Berlin: Walter de Gruyter, 1981; 315–326.

Yamashita, 1988, J Biol Chem, 263, 17482, 10.1016/S0021-9258(19)77861-2

Yamashita, 1987, J Biol Chem, 262, 1602, 10.1016/S0021-9258(19)75678-6

Aoyagi, 1988, Cancer, 61, 769, 10.1002/1097-0142(19880215)61:4<769::AID-CNCR2820610422>3.0.CO;2-M

Taga, 1988, Tumor Biol, 9, 110, 10.1159/000217551

Asaka, 1983, Gastroenterology, 84, 155, 10.1016/S0016-5085(83)80180-2

Mackiewicz, 1989, Clin Exp Immunol, 75, 70

Moriwaki, 1987, Am J Gastroenterol, 82, 1207

Toki, 1989, Z Kinderchir, 44, 246

Wu, 1990, Ann Clin Lab Sci, 20, 98